Keystone Symposia on Molecular and Cellular Biology: Host and the Environment in IBD: Scientific Advances Leading to New Therapeutics (A2)

Start Date: January 13, 2019

This is not a Crohn's & Colitis Foundation program, but is endorsed by the Foundation

Scientific Organizers: Gary D. Wu, Scott Snapper, Judy H. Cho and Aida Habtezion

Meeting Summary

Inflammatory bowel diseases (IBD), which afflict millions of patients, are rapidly increasing in incidence world-wide in parallel with industrialization. Pathogenesis involves both host genetic as well environmental factors, with the most currently utilized therapeutics focusing on long-term host immunosuppression. Despite tremendous advances in our understanding of IBD genetics, the mucosal immune system, and environmental factors such as the gut microbiome, currently available therapeutic modalities for IBD remain suboptimal. The overall goal of this conference is to bring together world-class investigators and clinicians to discuss the latest scientific knowledge relevant to the pathogenesis of IBD and facilitate an interactive discussion to accelerate development of new opportunities to prevent and/or treat IBD.

The specific aims of this conference are to:

  1. Bring together a combination of clinical and basic investigators from both academia and industry to facilitate cross-disciplinary discussions focused on IBD
  2. Identify both opportunities and gaps in current knowledge of the pathogenesis of IBD important for the development of new diagnostics and therapeutics; and 
  3. Create a multidisciplinary environment that will inspire both young and established investigators by highlighting currently available opportunities in IBD research. 

The anticipated outcome will be a better understanding of the advances and challenges in developing new therapies for patients with IBD.


1508 Paseo Del Pueblo Sur
Taos, New Mexico, 87571

For more information